Bahamondes L, Marchi N M, Nakagava H M, de Melo M L, Cristofoletti M de L, Pellini E, Scozzafave R H, Petta C
Departamento de Tocoginecologia, Universidade Estadual de Campinas (UNICAMP), Brazil.
Contraception. 1997 Nov;56(5):301-4. doi: 10.1016/s0010-7824(97)00162-5.
The objective of this study was to evaluate women's acceptance of and ability to self-administrate the injectable contraceptive Cyclofem using prefilled UniJect devices. A total of 102 women were invited to participate in the study. Fourteen women (13.7%) refused to participate. Of the remaining 88 women, 32 women (31.4%) consented to participate and were trained using oranges but were still afraid of the procedure and ultimately refused to self-administer the injections. Only 56 women (55%) ultimately self-injected Cyclofem with UniJect. They performed a total of 144 injections, all of them on the ventral side of the thigh. When nurses evaluated women's ability to activate the devices, they found that more than 80% were successful in both the group of women that later self-administered the injections and the group that did not. The evaluation of the self-administered injection technique showed that more than 90% of the women correctly self-administered the contraceptive using UniJect. With respect to the opinion of the women about the self-administration of the contraceptive, more than 50% (32 of 56) of women who self-injected preferred to self-administer the injection and said that they wished to continue with the self-administration, one-third (17) reported that they were afraid, and seven women (12.5%) expressed the opinion that the injection in the thigh was more painful than the administration in the buttocks or arm. In conclusion, our study showed that women can be trained to successfully self-administer the monthly injectable contraceptive Cyclofem and generally respond positively to UniJect.
本研究的目的是评估女性对使用预填充单剂量注射器装置的注射用避孕药Cyclofem的接受程度和自我给药能力。共有102名女性被邀请参与该研究。14名女性（13.7%）拒绝参与。在其余88名女性中，32名女性（31.4%）同意参与并使用橙子进行了培训，但仍害怕该操作，最终拒绝自我注射。只有56名女性（55%）最终使用单剂量注射器自行注射了Cyclofem。她们总共进行了144次注射，均在大腿前侧。当护士评估女性启动装置的能力时，他们发现后来自行注射的女性组和未自行注射的女性组中，超过80%的人都成功启动了装置。对自我注射技术的评估表明，超过90%的女性使用单剂量注射器正确地自行注射了避孕药。关于女性对避孕药自我给药的看法，自行注射的女性中超过50%（56名中的32名）更喜欢自行注射，并表示希望继续自行给药，三分之一（17名）报告说她们害怕，7名女性（12.5%）表示认为大腿注射比臀部或手臂注射更疼。总之，我们的研究表明，女性可以接受培训以成功自行注射每月一次的注射用避孕药Cyclofem，并且总体上对单剂量注射器反应积极。
